SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006453
Filing Date
2024-05-02
Accepted
2024-05-02 07:15:29
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20240331x10q.htm   iXBRL 10-Q 2274195
2 EX-10.1 bcyc-20240331xex10d1.htm EX-10.1 45788
3 EX-31.1 bcyc-20240331xex31d1.htm EX-31.1 14206
4 EX-31.2 bcyc-20240331xex31d2.htm EX-31.2 14396
5 EX-32.1 bcyc-20240331xex32d1.htm EX-32.1 10538
  Complete submission text file 0001558370-24-006453.txt   9527466

Data Files

Seq Description Document Type Size
6 EX-101.SCH bcyc-20240331.xsd EX-101.SCH 89305
7 EX-101.CAL bcyc-20240331_cal.xml EX-101.CAL 49761
8 EX-101.DEF bcyc-20240331_def.xml EX-101.DEF 355041
9 EX-101.LAB bcyc-20240331_lab.xml EX-101.LAB 613398
10 EX-101.PRE bcyc-20240331_pre.xml EX-101.PRE 513964
91 EXTRACTED XBRL INSTANCE DOCUMENT bcyc-20240331x10q_htm.xml XML 1407304
Mailing Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS
Business Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 24905260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)